Literature DB >> 9435255

Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands.

G Shyamala1, X Yang, G Silberstein, M H Barcellos-Hoff, E Dale.   

Abstract

In this report we document the creation of transgenic mice in which the native ratio of A and B forms of progesterone receptor (PR) has been altered by the introduction of additional A form as transgene. We also show that in these mice there is an aberration in mammary development. In ovariectomized prepubertal PR-A transgenic mice, end buds with unusual morphology persist after ovariectomy, and in young adult nonovariectomized mice, mammary glands have extensive lateral branching. The glands of adult mice also exhibit ductal hyperplasia with a disorganized basement membrane and decreased cell-cell adhesion, features commonly associated with neoplasia. Because progesterone is a mitogenic hormone in mammary glands and PR is required for mammary development, these data provide direct evidence that in vivo a regulated expression of the two isoforms of PR is critical for appropriate cellular response to progesterone and that for mammary glands this may have major implications to carcinogenesis.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1998        PMID: 9435255      PMCID: PMC18483          DOI: 10.1073/pnas.95.2.696

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Endocrine control of mammarygland development and function in the C3H/ He Crgl mouse.

Authors:  S NANDI
Journal:  J Natl Cancer Inst       Date:  1958-12       Impact factor: 13.506

2.  Proliferative and secretory activity in human breast during natural and artificial menstrual cycles.

Authors:  J J Going; T J Anderson; S Battersby; C C MacIntyre
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

Review 3.  Ectopic expression in Drosophila.

Authors:  A H Brand; A S Manoukian; N Perrimon
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

4.  Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene.

Authors:  B D'souza; J Taylor-Papadimitriou
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

5.  Progesterone receptors in the mouse mammary duct: distribution and developmental regulation.

Authors:  G B Silberstein; K Van Horn; G Shyamala; C W Daniel
Journal:  Cell Growth Differ       Date:  1996-07

6.  RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism.

Authors:  D P McDonnell; M E Goldman
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

7.  Differential effect of forms A and B of human progesterone receptor on estradiol-dependent transcription.

Authors:  D Chalbos; F Galtier
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

8.  Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography.

Authors:  C W Daniel; G B Silberstein; P Strickland
Journal:  Cancer Res       Date:  1987-11-15       Impact factor: 12.701

9.  Cloning of the rat progesterone receptor gene 5'-region and identification of two functionally distinct promoters.

Authors:  W L Kraus; M M Montano; B S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  1993-12

10.  Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast.

Authors:  D J Ferguson; T J Anderson
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

View more
  55 in total

Review 1.  Progesterone signaling and mammary gland morphogenesis.

Authors:  G Shyamala
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

Review 2.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

Review 3.  Establishing a framework for the functional mammary gland: from endocrinology to morphology.

Authors:  Russell C Hovey; Josephine F Trott; Barbara K Vonderhaar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

Review 4.  Hormonal control of alveolar development and its implications for breast carcinogenesis.

Authors:  Cathrin Brisken
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

Review 5.  Progesterone receptors in mammary gland development and tumorigenesis.

Authors:  Orla M Conneely; Biserka M Jericevic; John P Lydon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

6.  Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo.

Authors:  Rainer B Lanz; Steven S Chua; Niall Barron; Bettina M Söder; Francesco DeMayo; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.

Authors:  F De Amicis; S Zupo; M L Panno; R Malivindi; F Giordano; I Barone; L Mauro; S A W Fuqua; S Andò
Journal:  Mol Endocrinol       Date:  2009-01-15

8.  Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.

Authors:  Caroline H Diep; Todd P Knutson; Carol A Lange
Journal:  Mol Cancer Res       Date:  2015-11-17       Impact factor: 5.852

Review 9.  Expression profiling of human breast cancers and gene regulation by progesterone receptors.

Authors:  Britta M Jacobsen; Jennifer K Richer; Carol A Sartorius; Kathryn B Horwitz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

Review 10.  A reappraisal of progesterone action in the mammary gland.

Authors:  J P Lydon; L Sivaraman; O M Conneely
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-07       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.